In conversation with...

Prasad Kulkarni on the Covishield vaccine

November 30, 2021 EClinicalMedicine
In conversation with...
Prasad Kulkarni on the Covishield vaccine
Show Notes

Prasad Kulkarni, Medical Director of the Serum Institute of India, discusses his recent phase 2/3 trial on the Covishield vaccine published in eClinicalMedicine, as well as its implications for COVID vaccine development in general.